Logo image of GIAC

Gesher I Acquisition Corporation (GIAC) Stock Fundamental Analysis

NASDAQ:GIAC - Nasdaq - KYG385371094 - Common Stock - Currency: USD

10.2301  +0.49 (+4.98%)

After market: 14.3 +4.07 (+39.78%)

Fundamental Rating

1

Overall GIAC gets a fundamental rating of 1 out of 10. We evaluated GIAC against 0 industry peers in the Unkown industry. The financial health of GIAC is average, but there are quite some concerns on its profitability. GIAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GIAC had negative earnings in the past year.
GIAC had a negative operating cash flow in the past year.
GIAC Yearly Net Income VS EBIT VS OCF VS FCFGIAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 -5K -10K

1.2 Ratios

The profitability ratios for GIAC are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GIAC Yearly ROA, ROE, ROICGIAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 -50 -100

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for GIAC so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GIAC Yearly Profit, Operating, Gross MarginsGIAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021

More info and screens

4

2. Health

2.1 Basic Checks

GIAC Yearly Shares OutstandingGIAC Yearly Shares OutstandingYearly Shares Outstanding 2021 5M 10M
GIAC Yearly Total Debt VS Total AssetsGIAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 50K 100K 150K 200K

2.2 Solvency

An Altman-Z score of 13.12 indicates that GIAC is not in any danger for bankruptcy at the moment.
There is no outstanding debt for GIAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.12
ROIC/WACCN/A
WACCN/A
GIAC Yearly LT Debt VS Equity VS FCFGIAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2K 4K 6K 8K 10K

2.3 Liquidity

GIAC has a Current Ratio of 0.18. This is a bad value and indicates that GIAC is not financially healthy enough and could expect problems in meeting its short term obligations.
GIAC has a Quick Ratio of 0.18. This is a bad value and indicates that GIAC is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.18
GIAC Yearly Current Assets VS Current LiabilitesGIAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 50K 100K 150K 200K

More info and screens

1

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25724.03%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 355.27% on average over the next years. This is a very strong growth
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2Y-2195.73%
EPS Next 3Y-552.99%
EPS Next 5Y355.27%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GIAC Yearly Revenue VS EstimatesGIAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
GIAC Yearly EPS VS EstimatesGIAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GIAC reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GIAC Price Earnings VS Forward Price EarningsGIAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GIAC Per share dataGIAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

GIAC's earnings are expected to decrease with -552.99% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2195.73%
EPS Next 3Y-552.99%

More info and screens

0

5. Dividend

5.1 Amount

GIAC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Gesher I Acquisition Corporation

NASDAQ:GIAC (1/25/2023, 8:00:02 PM)

After market: 14.3 +4.07 (+39.78%)

10.2301

+0.49 (+4.98%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap149.10M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.35
P/tB 1.35
EV/EBITDA N/A
EPS(TTM)-0.21
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS0
BVpS7.56
TBVpS7.56
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.18
Altman-Z 13.12
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25724.03%
EPS Next YN/A
EPS Next 2Y-2195.73%
EPS Next 3Y-552.99%
EPS Next 5Y355.27%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-124074%
EBIT Next 3Y-791.93%
EBIT Next 5Y575.01%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A